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Many classes of S-adenosylmethionine (SAM)-bind-
ing RNAs and proteins are of interest as potential
drug targets in diverse therapeutic areas, from infec-
tious diseases to cancer. In the former case, the
SAM-I riboswitch is an attractive target because
this structured RNA element is found only in bacterial
mRNAs and regulates multiple genes in several
human pathogens. Here, we describe the synthesis
of stable and fluorescent analogs of SAM in which
the fluorophore is introduced through a functionaliz-
able linker to the ribose. A Cy5-labeled SAM analog
was shown to bind several SAM-I riboswitches via
in-line probing and fluorescence polarization assays,
including one from Staphylococcus aureus that
controls the expression of SAM synthetase in this
organism. A fluorescent ligand displacement assay
was developed and validated for high-throughput
screening of compounds to target the SAM-I ribos-
witch class.
INTRODUCTION
Riboswitches are structured RNA elements typically found in
bacterial mRNA untranslated regions that are capable of sensing
cellular metabolites (Breaker 2011). Binding of the cognate
ligand to the riboswitch aptamer domain affects a conforma-
tional change in the expression platform, resulting in regulation
of downstream gene expression. To date, more than 20 classes
of natural riboswitches have been discovered (Serganov and
Nudler, 2013) that bind a wide variety of metabolites. These
metabolites range in structure from simple amino acids such
as glycine, to large and elaborate cofactors such as adenosylco-
balamin, to the fluoride ion. The diversity of riboswitch ligands
reveals the intrinsic potential of structured RNA elements to
form binding pockets for specific molecular recognition.
Due to their roles in bacterial gene regulation and prospects of
targeting the ligand binding pocket of the aptamer domain,
riboswitches have generated interest for the development of
novel antibiotics (Blount and Breaker, 2006; Deigan and Ferre´-
D’Amare´, 2011). Subversion of the normal regulatory responseChemistry & Biology 21, 3of the riboswitch by an exogenous compound may disable the
function of essential genes and slow bacterial growth. The
availability of ligand-bound crystal structures for many ribos-
witch classes has made it possible to identify ligand analogs
by structure-based rational design (Deigan and Ferre´-D’Amare´,
2011). For example, bactericidal compounds have been identi-
fied that target the lysine riboswitch (Blount et al., 2007; Budha-
thoki et al., 2012) and guanine riboswitch (Kim et al., 2009;
Mulhbacher et al., 2010). Computational docking also has
been used to predict new ligands for the guanine riboswitch;
however, there is not a strong correlation between docking score
and ligand affinity (Daldrop et al., 2011).
Alternatively, the development of high-throughput screening
methodsoffers a separate approach for riboswitch liganddiscov-
ery. High-throughput methods allow rapid screening of more
diverse sets of compounds, enabling discovery of candidate
leads that would not be predicted by rational design. In addition,
this approach takes advantage of the large and diverse chemical
compound libraries that are available. Both fluorescence polari-
zation and FRET-based assays have been developed for
screening activators of the glmS riboswitch using fluorescently
tagged oligonucleotides (Mayer and Famulok, 2006; Blount and
Breaker, 2006). These screening techniques take advantage of
the natural self-cleaving ability of the glmS ribozyme; however,
they are limited by slow ribozyme kinetics and false-positive re-
sults from ligand-independent cleavage (de Silva and Walter,
2009). Although an allosteric ribozyme was engineered for the
Vc2 c-di-GMP riboswitch to develop a similar screening assay
(Furukawa et al., 2012), the method requires extensive optimiza-
tion for each riboswitch sequence of interest.
Other screening techniques have been developed for ribos-
witches that do not have ribozyme activity. An equilibrium dial-
ysis assay was used to screen a library of 1300 fragments for
activity against the Escherichia coli thiM TPP riboswitch (Cres-
sina et al., 2011; Chen et al., 2010). However, the method
requires tritium-labeled thiamine and the fragments were
screened in sets of five to increase throughput, necessitating
an additional deconvolution step after the initial screen. We
recently have described the development of a microfluidics-
basedmobility shift assay that has promising quantitative analyt-
ical capabilities in addition to being time and resource sparing
(Karns et al., 2013). Adaptation of this technology to a multiplex
format would be highly desirable for high-throughput screening.
Recently, a dual molecular beacon assay was described for
the Bacillus subtilis pbuE adenine riboswitch in which ligand45–356, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 345
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(Chinnappan et al., 2013). In contrast to other methods, this sys-
tem enables cotranscriptional screening of ligand analogs in a
functional context, which is important as kinetic parameters
are known to be critical for riboswitch function (Wickiser et al.,
2005). Thus, this method identifies compounds that not only
bind the riboswitch aptamer, but also affect the transcriptional
regulatory activity of the riboswitch. Although this assay has
been demonstrated only in a low-throughput format, the tech-
nique is potentially amenable to high-throughput screening.
However, optimization of the molecular beacons for each indi-
vidual riboswitch sequence is still required and compounds
with intrinsic fluorescence, transcriptional inhibitory activity, or
that affect the molecular beacons themselves must be avoided
(Chinnappan et al., 2013).
SAM-binding riboswitches have been largely unexplored as
targets for novel antibiotics, even though seven different classes
have been reported (SAM-I through SAM-V, SAM-I/IV, and SAM/
SAH) that each have distinct structural features (Wang and
Breaker, 2008; Batey 2011). These riboswitches have been
extensively characterized both structurally (Baird and Ferre´-
D’Amare´, 2010; Montange and Batey, 2006; Gilbert et al.,
2008; Lu et al., 2008; Stoddard et al., 2010; Wilson et al., 2011)
and mechanistically (Garst et al., 2011; Breaker 2012; Haller
et al., 2011). Rationally designed SAM analogs to target the
SAM-II riboswitch aptamer have been described (Ham et al.,
2011), and S-2,6-diaminopurinylmethionine was shown to bind
the SAM-III riboswitch aptamer (Ottink et al., 2010). However,
while the SAM-I riboswitch class has been specifically proposed
as an antibacterial drug target (Blount and Breaker, 2006), it has
posed a challenge to existing screening methodology.
In this study, we set out to design fluorescently tagged SAM
analogs for use in a ligand displacement assay for targeting
SAM-I riboswitches (Figure 1A). A fluorescence-based assay
was recently developed for the purine riboswitch using 2-amino-
purine as the fluorescent ligand, and has considerable advan-
tages over other methods such as in-line probing and isothermal
titration calorimetry (Daldrop et al., 2011). Fluorescent SAM an-
alogs based on 2-aminopurine have been prepared (Ottink
et al., 2010); however, it is known that the 6-amino group is
important for SAM-I riboswitch binding affinity (Lim et al.,
2006). Instead, we considered developing fluorescently tagged
SAM analogs via installation of a functionalizable linker at
different positions.
Analysis of the three-dimensional crystal structures of the
SAM-I riboswitch aptamer bound to SAM (Montange and Batey,
2006, Lu et al., 2010) suggested the 20 and 30 ribose hydroxyl
groups of SAM 1 as candidate positions for fluorophore attach-
ment. Although numerous SAM analogs have been prepared for
use as protein substrates or inhibitors, there is currently only one
example of chemical modification at the 20 or 30 hydroxyl of the
ribose moiety (Li et al., 2011). In this work, we report the synthe-
sis of SAM analogs containing functionalized linkers installed
onto the 20 and 30 ribose hydroxyls and show that these analogs
retain binding to the SAM-I riboswitch. We further describe the
development of a fluorescence polarization assay using a fluo-
rescently tagged SAM analog for targeting SAM-I riboswitches.
We demonstrate a fluorescent ligand displacement assay for tar-
geting SAM-I riboswitches, including the Staphylococcus aureus346 Chemistry & Biology 21, 345–356, March 20, 2014 ª2014 ElseviemetK SAM-I sequence, that may be useful as a high-throughput
screening method for antibacterial drug discovery.
RESULTS
Synthesis and Evaluation of Two Functionalizable SAM
Analogs
For targeting SAM-I riboswitches, we sought to develop a syn-
thetic route that was amenable to the installation of functionaliz-
able linkers on the SAM ribose hydroxyl groups. The riboswitch
aptamer makes extensive contacts to both the nucleobase and
amino acid moieties of SAM 1 (Montange and Batey, 2006, Lu
et al., 2010), and functional group transformations at these posi-
tions are not well tolerated (Lim et al., 2006). However, the 20 and
30 ribose hydroxyls of SAM 1 are located within a solvent-acces-
sible cavity, and only the 20 hydroxyl is directly contacted
through hydrogen bonding interactions (Figure 1B).
Therefore, we designed two prototype analogs 2 and 3 con-
taining either a 20-30-O-acetal or 30-O-propionate linker, respec-
tively (Figure 2A). We based our design on a stable sulfone
analog of SAM 1 (SAH sulfone, 4) that has been shown to bind
the SAM-I riboswitch from the yitJ transcript of B. subtilis with
high affinity (Kd value of 30 nM; Lim et al., 2006). The electro-
positive character imparted on the sulfur atom by oxidation to
the sulfone leads to a higher affinity relative to S-adenosylhomo-
cysteine (SAH, 5), which has a Kd value of 400 nM (Lim et al.,
2006). Thus, we reasoned that fluorescently tagged versions of
4would be useful in competition binding assays to identify novel
riboswitch ligands.
It was envisioned that linkers first could be introduced to the
adenosine nucleoside followed by coupling to the homocysteine
portion. The 2-(methoxycarbonyl)ethylidine group has been
described as an unusually stable acetal protecting group for
1,2-diols (Ariza et al., 2000). As previously shown for 50-O-tritylur-
idine (Ariza et al., 2000), acetal formation was achieved cleanly
by reacting 50-chloroadenosine 6 with methyl propiolate and
DMAP. Because formation of the acetal is nonstereoselective,
we isolated and carried forward both diastereomers of 7 (60:40
R/S, diastereomers assigned by NOESY and ratio determined
by 1H nuclear magnetic resonance [NMR]).
Thioether formation was effected by coupling 7 with Boc-L-
homocysteine following a procedure developed in our lab for effi-
cient preparation of SAH 5 and other analogs (unpublished data).
These conditions also led to hydrolysis of the methyl ester.
Oxidation of the thioether to the sulfone using urea-hydrogen
peroxide and trifluoroacetic anhydride (Balicki, 1999) followed
by trifluoroacetic acid deprotection yielded the 20-30-O-acetal
linked analog 2. Thus, in addition to stability to strong acid and
methanolysis (Ariza et al., 2000), we have shown that this acetal
is stable to aqueous base even at slightly elevated temperatures
andmild oxidation conditions. Some depurination was observed
during acid deprotection, contributing to the relatively low yield
of the last step. Unfortunately, we were unable to adequately
separate the two diastereomers by HPLC, so the binding
analysis was performed on the mixture.
In the X-ray crystal structure of the B. subtilis 118 yitJ SAM-I
riboswitch aptamer, the 20 hydroxyl of SAM 1 is observed to
make two hydrogen bonds, one with the ribose sugar moiety
of residue C48 and the other with the O2-carbonyl of residuer Ltd All rights reserved
Figure 1. Structure-Based Rational Design of a Fluorescently Tagged Ligand Analog that Targets the SAM-I Riboswitch
(A) Schematic representation of a fluorescent ligand displacement assay for the SAM-I riboswitch. Fluorescent SAM analog is displaced by unlabeled competitor,
leading to decrease in fluorescence polarization in a dose-dependent manner. Chemical structures of SAM 1, SAH sulfone 4, SAH 5, and C8-Cy5 18 are shown.
(B) The X-ray crystal structure of a B. subtilis SAM-I riboswitch bound to SAM (PDB code 3NPB) shows that the SAM ribose hydroxyls are solvent accessible. The
20-hydroxyl makes hydrogen bonding contacts to C48 and U112 of the riboswitch.
See also Figure S3.
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analog 3 is proposed to retain these interactions. Because the
synthesis of this analog requires mono-alkylation of the 30 hy-
droxyl, we first considered methods for selective protection of
the 20 hydroxyl. It was found that the TIPDS (tetraisopropyldisilyl)
group, which masks both 50 and 30 hydroxyls (Puffer et al., 2008),
was not stable to subsequent reaction conditions. Instead, it was
more straightforward to react adenosine with PMB chloride
directly (Benito et al., 2008) because the 20-O-PMB protected
product selectively recrystallizes from solution. If desired, the
30-O-PMB protected product remaining in the filtrate can be re-
cycled back to the starting material, adenosine.
While the 50 chlorination proceeded smoothly to give 9, the re-
maining 30 hydroxyl group was quite unreactive. To install the 30-Chemistry & Biology 21, 3O-propionate linker, the best yields were obtained by running the
reaction in neat methyl acrylate with tert-butoxide. The strong
base was added in portions during the course of the reaction
to avoid a second alkylation, presumably occurring on the N6
amino group of adenosine, which otherwise leads to a less polar
di-alkylated byproduct observed by TLC and LCMS. Under
these conditions, we observed preferential alkylation of the 30
hydroxyl, as the sole mono-alkylated product exhibits a broad
singlet integrating to two protons in the 1HNMR spectrum, which
is indicative of the N6 amino group. Finally, the 30-O-propionate
linked SAH sulfone analog 3 was obtained from the standard
coupling reaction, followed by oxidation to the sulfone and de-
protection with acid to remove both Boc and PMB protecting
groups.45–356, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 347
Figure 2. Scheme of Prototype Analogs 2 and 3
(A) Synthetic route to prototype compounds containing 20-30-O-acetal (2, top) and 30-O-propionate (3, bottom) linkers to SAH sulfone. See also Figure S2.
(B) Synthetic route to C3 and C8 linker-containing intermediates 16 and 17. See also Figure S2.
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with two different linkers to probe whether it was possible to
functionalize the ligand without blocking binding to the SAM-I
riboswitch. Thus, we compared the binding affinities of SAH sul-
fone 4 and these prototype linker-containing compounds to the
B. subtilis 124 yitJ SAM-I riboswitch aptamer (Bs SAM-I; Fig-
ure 3A). Dissociation constants for each ligand were determined
by performing in-line probing analysis (Regulski and Breaker,
2008) on Bs SAM-I in the presence of different concentrations
of compound (Figure 3B). The in-line cleavage pattern was iden-
tical for all compounds tested and matched that of SAM 1, with
the exception that residue C11 shows increased cleavage in the
presence of SAH sulfone 4 and its analogs relative to SAM 1,
consistent with previous observations (Lim et al., 2006). The Kd
value for SAH sulfone 4 synthesized using our method (29 nM)
matched the previously reported value of 30 nM (Lim et al.,
2006).
Furthermore, we found that both 2 and 3maintain strong bind-
ing affinity to the SAM-I riboswitch aptamer. The acetal linker
reduces affinity by 4.7-fold (Kd value of 140 nM). This loss of
affinity could be due at least partially to the absence of the 20 hy-
droxyl, which is involved in hydrogen-bonding interactions (Fig-
ure 1B). In support of this hypothesis, analog 3, which maintains
the 20 hydroxyl and bears the 30-O-propionate linker, binds the
SAM-I riboswitch aptamer with higher affinity than 2 (Kd value
of59 nM). While both model compounds 2 and 3 retain binding
affinity to the RNA, we considered the 30-O-propionate linker to
be more promising to pursue, because it has little negative effect
on binding and does not generate a new stereocenter.348 Chemistry & Biology 21, 345–356, March 20, 2014 ª2014 ElsevieFluorescently Tagged SAM Analogs Target the SAM-I
Riboswitch
To prepare fluorescent analogs, we considered that installing a
terminal amine on the 30 linker would allow us to take advantage
of the multitude of commercial amine-reactive fluorescent
probes (Figure 2B). Saponification of 10 followed by HATU
coupling to either mono Boc-protected 1,3-diaminopropane or
1,8-diaminooctane (Chadwick et al., 2010) gave 12 and 13,
respectively, showing that overall linker length can be modified
by simply exchanging the diaminoalkane used in the coupling re-
action. The corresponding SAH sulfone analogs were obtained
after employing similar thioether formation, oxidation, and de-
protection conditions as established for 3.
Mono protection of the diaminoalkane linker with Cbz also can
be effected, but we were concerned with having to perform late-
stage deprotection of this group in the presence of a thioether.
As the Fmoc protecting group likely is not stable to the condi-
tions for thioether formation, the Boc-protected diaminoalkanes
were used. Thus, the final deprotection of 14 and 15 removed
both Boc groups and revealed two potentially reactive amines.
Efforts to couple to the fluorophore NHS ester in the presence
of copper (II) sulfate to block the amino acid (Wiejak et al.,
1999) were unsuccessful. However, the ε-amine of lysine has
been shown to react with an NHS ester selectively over the
a-amine (Chauhan, 2009), so a similar effect was expected
with 16 and 17. Coupling of 5(6)-carboxytetramethylrhodamine
(TAMRA) NHS ester with 16 gave a 70:30 mixture of C3-TAMRA
regioisomers as monitored by HPLC, but with 17, which has a
longer alkyl chain, only the desired regioisomer (C8-TAMRA)r Ltd All rights reserved
Figure 3. Prototype Linker-Containing Ana-
logs of SAH Sulfone Maintain Affinity for Bs
SAM-I
(A) Comparison of binding affinities to the ri-
boswitch aptamer for analogs 2 and 3 versus SAH
sulfone 4 determined by in-line probing analysis.
Data shown are averages for several sites of
modulation normalized to the cleavage observed
at maximum ligand concentration, or the inverse
value (one minus normalized cleavage observed)
for sites of increasing cleavage. Also shown are
best-fit curves used to calculate Kd values. Error
bars represent SD of values for sites of modulation
analyzed from a single gel.
(B) Representative in-line probing gel showing
change in spontaneous cleavage pattern of Bs
SAM-I in the presence of 2. Sites of modulation
analyzed are marked by black triangles and
several G nucleotides mapped by T1 digest are
labeled. NR, no reaction; T1, partial digest with
RNase T1; and OH, partial digest with alkali.
See also Figure S4.
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TAMRA was confirmed by correlation to the 1H NMR chemical
shifts for the more extensively characterized Cy5-tagged com-
pound 18.
Other riboswitch-small molecule interactions have been inter-
rogated using a radiolabeled ligand in native polyacrylamide gel
electrophoresis (PAGE) (Shanahan et al., 2011). Similarly, bind-
ing of the TAMRA-tagged SAM analogs to Bs SAM-I was
analyzed using native PAGE. Both fluorescently tagged analogs
noncovalently labeled Bs SAM-I; however, the fluorescent
ligand-riboswitch complex was detectable at lower RNA con-
centrations for C8-TAMRA (250 nM) than for C3-TAMRA (5 mM;
Figure S1 available online). In-line probing analysis corroborates
the native PAGE results (Figure S1), which together suggest that
the longer C8 linker is better tolerated for binding to the ribos-
witch aptamer.
Coupling of sulfo-Cy5 NHS ester with 17, which was analyzed
by 2D COSY experiments to assign peaks in the 1H NMR (Fig-
ure S2), yielded the desired single regioisomer of C8-Cy5 18.
Consistent with fluorophore coupling to the C8 amine linker
instead of the amino acid, we observed a decrease in the number
of protons attached to the C8 amine from three to one (Figure S3).
In addition, the chemical shift of the adjacentmethylene changes
from 2.7 to 3.0 ppm (Figure S3), which was also observed for
acetylated 16 prepared from mono-acetyl diaminopropane.
Interestingly, the binding affinities of fluorescent ligands
C8-TAMRA (Kd value of 3 mM) and the related C8-Cy5 18
(Kd value of 2.8 mM) to Bs SAM-I (Figure 4A; Figure S1) are
similar, in spite of the latter having an additional alkyl spacer.
Both exhibit weaker than expected binding to the riboswitch
aptamer. This effect is not due to the presence of the linker, as
17 and acetylated 16 both retain relatively strong binding affin-
ities (Kd values of142 nM and 102 nM, respectively; Figure S4).
Riboswitch P3 Stem Length Affects Binding of a
Fluorescently Tagged SAM Analog
The X-ray crystal structure of the B. subtilis 118 yitJ SAM-I ribos-
witch aptamer (Lu et al., 2010) shows that the P3 stem drapesChemistry & Biology 21, 3over the solvent-accessible cavity leading to the ribose portion
of the ligand (Figures S5A and S5B). Thus, we propose that steric
hindrance with the P3 stem due to adding the TAMRA or Cy5
fluorophores to the flexible alkyl linker leads to the observed
detrimental effect on riboswitch binding. Alternatively, the fluoro-
phores may affect the conformation of the SAM analog in
solution, such that binding to the riboswitch aptamer is less
favorable. It also is possible that both factors contribute to the
loss in affinity for the fluorescently tagged ligand.
To determine whether the P3 stem contributes to steric clash,
we examined three previously characterized SAM-I riboswitch
aptamers with varying P3 stem lengths (Figure 4). The published
consensus sequence for the SAM-I riboswitch aptamer, which is
based on 4757 representative sequences fromdifferent bacteria,
shows that the length of the P3 stem is highly variable (Barrick
and Breaker, 2007). TheBs SAM-I riboswitch aptamer has a total
P3 stem length of 40 nucleotides, while the 115 nucleotide ribos-
witch aptamer sequence from the O-acetylhomoserine sulfhy-
drylase transcript of Polaribacter irgensii (Pi SAM-I) has a total
P3 stem length of 29 nucleotides. Both of these RNAs exhibit
similar binding affinities for SAM (Kd values of 4 nM and 3 nM,
respectively; Winkler et al., 2003, Karns et al., 2013). In addition,
we analyzed the crystallography construct used to obtain the
Thermoanaerobacter tengcongensis SAM-I riboswitch aptamer
structure (Tt SAM-I; Montange and Batey, 2006). This 94 nucle-
otide sequence derived from the metF transcript has an artifi-
cially shortened P3 stemof 19 nucleotides (Figure S5) and poorer
binding affinity for SAM (Kd of 130 nM as determined by
isothermal calorimetry; Montange and Batey, 2006).
To deconvolute the effect of sulfone substitution from the
effect of the fluorophore tag, the affinities for each riboswitch
aptamer to SAH sulfone 4 and fluorescently tagged 18 were
measured by the in-line probing assay (Figures 4 and S6). Inter-
estingly, the sulfone substitution had variable effects on binding
affinity to the different riboswitch aptamers (Table S1).
Comparing the binding affinities for SAM and SAH sulfone,
replacement of the sulfonium group with the sulfone leads to
similar fold increases in dissociation constants for the B. subtilis45–356, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 349
Figure 4. P3 Stem Length Analysis Reveals Major Effect on Relative Ligand Binding Affinity
(A–C) On left, sequences and secondary structure models mapped with in-line probing patterns are shown for (A) Bs SAM-I, (B) Pi SAM-I, and (C) Tt SAM-I. P3
stem lengths are labeled next to each sequence. On right, corresponding in-line probing data and best-fit curves used to calculate Kd values are shown. Error bars
represent SD of values for sites of modulation analyzed from a single gel. Relative fold-change in affinity between compounds 4 and 18 is labeled in red.
(D) Plot of the difference in free energy for the dissociation of 18 and 4 versus length of the riboswitch aptamer P3 stem.
See also Figure S6 and Table S1.
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respectively). This result matches the observation that the ligand
binding pockets for these two aptamers are virtually superim-
posable (Lu et al., 2010). In contrast, there is a much larger effect
of sulfone substitution for the P. irgensii riboswitch aptamer
(25-fold), but the cause of this is not entirely clear without further
structural information. As expected, the effect of the sulfone
substitution does not correspond to the P3 stem length, which
does not play a direct role in recognition of the sulfonium group
(Montange and Batey, 2006; Lu et al., 2010).
In contrast, comparison of dissociation constants for 4 and 18
shows that addition of the fluorophore tag has a detrimental
effect on binding affinity that increases with P3 stem length (Fig-
ure 4; Table S1). Strikingly, this correlation is linear (Figure 4D),
and together with analysis of the two crystal structures (Fig-
ure S5) supports the hypothesis that a longer P3 stemmay cause
steric interference with binding of the fluorescently tagged SAM
analog. However, this effect is masked by differences in ligand
recognition because the P3 stem also is involved in recognition
of the adenosine base of SAM, so the binding affinity of 18 for
Tt SAM-I is still poorer than that for Bs SAM-I. Similarly, we
have observed that SAM-I riboswitch aptamers with naturally
short P3 stems also exhibit poor binding affinity for 18 (Figures
S5C and S5D).
The above results do not eliminate the possibility that addition
of the linked fluorophore changes the conformation of the SAM
analog in solution. It was previously observed that the fluores-
cence of flavin adenine dinucleotide is decreased relative to
flavin mononucleotide due to the adenine moiety stacking with
the isoalloxazine ring (Li and Glusac, 2008). Similarly, we consid-350 Chemistry & Biology 21, 345–356, March 20, 2014 ª2014 Elsevieered that if Cy5 has the propensity to stack with the adenine
portion of the SAM analog, one would observe an increase in
fluorescence going from this conformation in solution to un-
stacked upon binding to the riboswitch aptamer. However, there
was little difference between the fluorescence intensity of 18
upon addition of water or Bs SAM-I (Figure S7), which suggests
that binding does not significantly alter ligand conformation. For
the same samples, formation of the riboswitch-ligand complex
was confirmed by an observed increase in fluorescence polari-
zation (FP).
We further considered that if the fluorescently tagged ligand
was prone to aggregation, one would observe an increase in
fluorescence polarization upon titration of the ligand. However,
while fluorescence intensity increases linearly with respect to
compound concentration, the fluorescence polarization was
insensitive to changes in ligand concentration up to the value
used in binding experiments (Figure S7). The latter observation
reveals that the fluorescently tagged ligand is not aggregated
under our assay conditions. Thus, these data together suggest
that the length of P3 stem of the SAM-I riboswitch affects ac-
commodation of the fluorophore tag attached via the ribose 30
hydroxyl; however, we cannot rule out that other differences in
the aptamer domains contribute to disrupt binding to 18.
Development of Direct and Competitive Fluorescence
Polarization Binding Assays for SAM-I Riboswitches
With the C8-Cy5 fluorescent ligand 18 in hand, we sought to
develop an FP binding assay for SAM-I riboswitches. Previous
analysis by the in-line probing assay showed that the fluores-
cently tagged ligand binds to different SAM-I riboswitchr Ltd All rights reserved
Figure 5. Application of C8-Cy5 18 to Fluorescence Polarization
Binding Assays with Multiple SAM-I Riboswitch Aptamers
Fluorescence polarization of 18 is shown upon titration with (A) WT Bs SAM-I,
(B) P2 mutant Bs SAM-I, (C) Pi SAM-I, and (D) Sa SAM-I. Different symbols
indicate independent replicates. Change in polarization (DP) was normalized to
the maximal difference observed at the highest RNA concentration. The re-
ported Kd value is the average of those calculated from best-fit curves with
margin of error reported as SD.
See also Figure S1.
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the riboswitch-ligand complex by increase in FP signal upon
titration of the WT Bs SAM-I RNA, while no change in FP signal
was observed upon titration of a mutant Bs SAM-I RNA
harboring a disruptive mutation in the P2 stem (Heppell and
Lafontaine, 2008; Figures 5A and 5B). Furthermore, the dissoci-
ation constants determined from the FP binding assay (4.5 ±
1.2 mM and 2.6 ± 0.1 mM for Bs and Pi SAM-I, respectively) are
in good agreement with those determined by in-line probing
assays.
S. aureus is the causative pathogenic agent of a significant
portion of hospital-acquired infections (Otto, 2012). The
S. aureus metK gene encodes S-adenosylmethionine synthe-
tase, which has been shown to be essential in E. coli (Wei and
Newman, 2002) and B. subtilis (Kobayashi et al., 2003) and is
predicted to be essential in S. aureus according to shotgun
antisense RNA analysis (Forsyth et al., 2002). The expression
of this gene is regulated by a computationally predicted SAM-I
riboswitch, which represents a potential target for the develop-
ment of new antibiotics (Blount and Breaker, 2006). Using the
FP binding assay, we found that the S. aureus 114 metK SAM-I
riboswitch aptamer (Sa SAM-I) binds to the fluorescently tagged
SAM analog 18 with a Kd of 5.2 ± 0.6 mM, which is similar to theChemistry & Biology 21, 3dissociation constants determined for the other two SAM-I
riboswitches.
We next used 18 to develop a competitive ligand displacement
assay for targeting SAM-I riboswitches. The ability of SAH, SAH
sulfone, and adenosine to displace 18 from Bs SAM-I and Sa
SAM-I was assayed (Figure 5). The first two compounds are ex-
pected to be competitive ligands, and indeed titration of these
compounds leads to a decrease in FP signal. In contrast, aden-
osine does not bind Bs SAM-I at concentrations up to 25 mM
(Winkler et al., 2003), and our FP results are consistent with it
being a non-binder (Figures 6C and 6F). The data were fit to
equations for complete competitive binding (Roehrl et al.,
2004) and half-maximal inhibitory concentration (IC50) values
were calculated for SAH and SAH sulfone using nonlinear regres-
sion analysis. The IC50 values correlate to but do not match the
Kd values for these two ligands (30 and 400 nM, respectively,
for Bs SAM-I; Lim et al., 2006). The difference is due to the rec-
ommended design of competition experiments, in which the
starting polarization represents 50%–80% of the maximal value
(Kishor et al., 2013). Under these conditions, total RNA concen-
tration is high and the IC50 values can be overestimations of the
Kd values (Cheng and Prusoff, 1973, Swillens, 1995). Neverthe-
less, the IC50 values for SAH and SAH sulfone with both ribos-
witch aptamers show the expected trend, which is that SAH is
a poorer affinity ligand than SAH sulfone. These results suggest
that the fluorescent ligand analog 18 can be used to screen
compound libraries for lead compounds that bind to Sa SAM-I,
a potential antibiotic target.
To further validate that the FP competitive ligand displace-
ment assay can be adapted for high-throughput screening, we
determined the Z0 factor for performing the assay in a 384-well
plate in place of the single cuvette format. The Z’ factor provides
a measure of assay quality for high-throughput screening (HTS)
and accounts for the dynamic range and well-to-well variation
of an assay (Zhang et al., 1999). An excellent HTS assay by
industry standards has a Z0 factor between 0.5 and 1.0; however,
HTS assays with Z0 factors between 0.2 and 0.5 can still be infor-
mative (Zhang et al., 1999).
To determine Z0 factors for the competition assay, 16 well rep-
licates on a 384-well plate containing either no competitor or
100 mM of SAM were evaluated in the presence of Bs, Sa, or Pi
SAM-I and 18 by FP signal. Unfortunately, calculated Z0 values
for Bs and Sa SAM-I were 0.31 and 0.22, respectively (Figures
7A and 7B). We hypothesized that the low Z0 values for these
RNAs were attributed to the modest changes in FP signal
(DmP) for Bs and Sa SAM-I upon competitive displacement of
18 (61 and 46 mP, respectively, as measured by platereader,
similar to the overall signal change observed for the cuvette-
based assay; see Table S2). In contrast, the Pi SAM-I gave the
largest DmP upon competitive displacement of 18 (110 ± 22
mP), and consistent with this result, the Z0 value for Pi SAM-I
was calculated as 0.57 ± 0.01, representing an excellent HTS
assay (Figure 7C).
In addition, we evaluated 16 well replicates of two other com-
pounds, SAH sulfone or adenosine, at 100 mM concentrations
(Figure 7). Interestingly, at this high concentration, we observe
some minimal binding for adenosine to the SAM-I riboswitch
aptamers, which is consistent with the cuvette-based assay
results (Figures 6C and 6F). While SAH sulfone lies beyond the45–356, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 351
Figure 6. Competitive Ligands Displace C8-
Cy5 18 in a Dose-Dependent Manner as
Observed by Fluorescence Polarization
Calculated fraction bound are graphed for 18 upon
displacement by SAH sulfone 4 (white boxes),
SAH 5 (black boxes), or adenosine (gray boxes)
from (A–C)Bs SAM-I and (D–F) Sa SAM-I. Different
symbols indicate independent replicates. The re-
ported IC50 value is the average of those calcu-
lated from nonlinear regression analysis according
to a single-site competition model with margin of
error reported as SD.
See also Figure S5.
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FP signal of the no competitor sample, adenosine does not
meet this threshold and represents a non-hit compound. In
contrast, SAH sulfone also lies beyond the ‘‘hit’’ threshold as
defined by three SD away from the mean FP signal of the posi-
tive control, SAM, and so represents a true competitive ligand.
Similar ligand binding results are observed for each of the
RNAs, but only the assay employing Pi SAM-I has a wide signal
window for distinguishing between hits and non-hits, as re-
flected by a demonstrated Z0 factor in the range for a statistically
reliable high-throughput screen.
DISCUSSION
Fluorescence polarization has been widely adopted as a high-
throughput assay, as screening experiments can be fully auto-
mated using commercially available instrumentation (Jameson
and Ross, 2010). FP is commonly used for analysis of protein-
ligand and protein-nucleic acid interactions (Moerke, 2009) and
has been applied to detect metabolite-dependent activation of
the glmS riboswitch-ribozyme (Mayer and Famulok, 2006). How-
ever, prior to our study, it had not yet been explored for standard
riboswitch-ligand interactions.
For select riboswitch classes, the cognate ligand has intrinsic
fluorescence (Serganov et al., 2009) or can be directly
substituted with a fluorescent analog (Budhathoki et al., 2012;
Ottink et al., 2010; Daldrop et al., 2011). In each case, it was
found that fluorescence is quenched upon binding, and this
change in fluorescence has been used tomeasure ligand binding
and competitive displacement. We now have shown that a fluo-
rescently tagged riboswitch ligand can be used for measuring
ligand binding via fluorescence polarization. Similar to other fluo-
rescence-basedmethods, the FP assay enables rapid and direct
sample analysis with high sensitivity and without needing a sep-
aration step. Furthermore, the reproducibility of the FP signal is
increased by its relative insensitivity to changes in fluorophore352 Chemistry & Biology 21, 345–356, March 20, 2014 ª2014 Elsevier Ltd All rights reservedconcentration (Lea and Simeonov,
2011), which improves statistical signifi-
cance parameters for high-throughput
formats. Also, in contrast to assays that
rely on changes in fluorescence intensity,
ligands can be covalently tagged with a
convenient and bright fluorophore at any
position that does not disrupt binding.These advantages have made FP-based competition binding
assays a workhorse HTS method in the clinical and biomedical
fields (Jameson and Ross, 2010), and we expect that it will prove
useful for riboswitch-targeted drug discovery as well.
For FPassays,minimal effects on thequantumyielduponbind-
ing of the fluorophore are preferable, so the fluorescent tag needs
to be placed outside of the ligand binding pocket. It was chal-
lenging to rationally design a fluorescently tagged ligand for
the SAM-I riboswitch class, because almost every functional
group of SAM is recognized by the RNA and the electropositive
sulfonium center is hydrolytically unstable. Using two prototype
analogs based on SAH sulfone, we explored the possibility of
installing a linker to the ribose hydroxyls and found that the 30
position tolerated functionalization. As planned, fluorophore
conjugation to the alkyl amine linker was the last synthetic step,
which enables modification of fluorescent properties through
choice of the NHS ester reagent (e.g., TAMRA, Cy5) and mini-
mizes the required amount of the expensive fluorophore reagent.
Although RNA-protein interactions typically display larger
changes in fluorescence polarization, the FP signal for 18 bound
to SAM-I riboswitch aptamers is similar to what has been
observed for other RNA-small molecule interactions (Tok et al.,
1999). Interestingly, under the conditions of the cuvette-based
FP assay, the signal for 18 bound to Bs SAM-I is larger than for
Sa SAM-I (68 versus 43 mP, respectively, see Table S2), in spite
of the two RNAs having similar molecular weights and structural
folds. Importantly, the dynamic range of the FP signal of 18 was
sufficient for determination of Kd and IC50 values for ligands and
competitors, respectively, for both SAM-I riboswitch aptamers.
To translate the FP competition assay from cuvette-based to
384-well format, we found it necessary to improve the dynamic
range of the FP signal for increased statistical significance as
measured by the Z’ factor. This was accomplished using Pi
SAM-I, which had a much larger DmP (110 ± 22 mP) compared
to Sa SAM-I (46 mP). Thus, fluorescently tagged 18 enabled
facile screening of multiple SAM-I riboswitch aptamer
Figure 7. Z0 Values Determined through 384-Well Format Fluores-
cence Polarization Competitive Ligand Displacement Assay
Fluorescence polarization of 18 graphed for 16 well replicates containing (A)
Bs, (B) Sa, and (C) Pi SAM-I with no competitor or 100 mM of SAM, SAH
sulfone, or adenosine. The dashed black line indicates the mean (m) and the
solid black bracket indicates the SD for each replicate set. Also shown is the
signal window for identifying hits defined by m  3SD for no competitor (red
dashed line) and m + 3SD for the SAM control (blue dashed line). The Z0 value
shown is the average of three plate replicates for Pi, or single plate replicates
for Bs and Sa.
See also Figure S7 and Table S2.
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an interesting target for drug discovery, we expect that com-
pounds that bind this RNA found by HTS would be a promising
set of candidate ligands for screening against Sa SAM-I.
Preliminary hits from a high-throughput binding assay like the
one we have developed would need to be further validated, as
binding alone does not necessarily confer modulation of theChemistry & Biology 21, 3riboswitch regulatory function. However, our assay has the
potential to identify compounds that bind within the ligand
binding pocket of the riboswitch, as the assay signal is correlated
to displacement of the fluorescently tagged SAM analog.
Thus there is the strong likelihood of identifying competitor com-
pounds that stabilize the P1 in a manner analogous to the
cognate ligand SAM. In addition, two SAM-I expression plat-
forms recently were shown to trigger transcriptional termination
in the presence of either theophylline or tetracycline when the
expression platforms were fused to the corresponding in vitro
evolved aptamer (Ceres et al., 2013). The results from that study
suggest that a simple binding event is sufficient to induce regu-
lation through stabilization of the P1 helix. Nevertheless, it is
expected that compound leads could be further validated using
more low-throughput functional screens, such as the molecular
beacon assay (Chinnappan et al., 2013) or the two-piece
switching assay recently developed for the T. tengcongensis
metF SAM-I (Hennelly and Sanbonmatsu, 2011).
In this study, we have demonstrated that there is a signal
threshold for adapting FP assays for RNA-small molecule inter-
actions to the HTS format. The FP assay requires optimization
of the fluorescently tagged ligand, and we further showed that
it may be beneficial to screen related RNA targets in the HTS
format. We recommend a practical limit for DmP in the 384-
well format of above 80 mP when using a manual multichannel
pipette because the SD between replicates is typically 10%–
15%. However, use of an automated pipetting system should
decrease SD to 3%–4% and allow the DmP to be considerably
lower (40mP;Mayer and Famulok, 2006).We expect that these
results may inform FP-based HTS screening efforts for small
molecule drug candidates against other therapeutic RNA targets
in general (Thomas and Hergenrother, 2008).
Although knowledge of the structure of the riboswitch-ligand
complex aided in the design of the Cy5-tagged analog 18, the
binding affinity of this compound was poorer than expected
given the results for the linker-containing prototype 3. However,
individual members of the SAM-I riboswitch class with higher
affinity for 18 may exist. The FP assay readily allows screening
for such variants in a riboswitch aptamer library because it
does not require chemical modification or labeling of each
RNA. Furthermore, additional riboswitch classes that bind SAM
as the cognate ligand have been described (Gilbert et al.,
2008; Lu et al., 2008; Weinberg et al., 2008) that may bind 18
as well. Experiments for targeting other SAM riboswitch classes
are currently in progress.
Additionally, SAM-binding proteins such as histone methyl-
transferases represent interesting therapeutic targets and have
been the focus of drug discovery efforts in recent years. For
example, the lysine methyltransferase SET7/9 has generated
interest as a drug target for type II diabetes, AIDS, and
hormone-dependent breast cancer (Wagner and Jung, 2012).
Also, the G9a methyltransferase is upregulated in lung, prostate,
and hepatocellular carcinoma (Wagner and Jung, 2012). X-ray
crystal structures of each of these enzymes with inhibitor bound
suggest that the SAM ribose hydroxyls are solvent accessible
when bound to the protein (Protein Data Bank [PDB] codes
4E47 for SET7/9 and 3K5K for G9a) (Liu et al., 2009). Further-
more, hydrogen bonding interactions to the ribose hydroxyls
are not conserved in SET domain HMTs (Campagna-Slater45–356, March 20, 2014 ª2014 Elsevier Ltd All rights reserved 353
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G9a (Minkui Luo, personal communication), it has been previ-
ously shown that these enzymes are inhibited by their byproduct
SAH 5 (Iba´n˜ez et al., 2010). Thus, from intermediate 15 of our
synthetic route, one could access a fluorescently tagged SAH
analog akin to 18 that potentially could be used to identify inhib-
itor compounds in an FP-based ligand displacement assay that
bind in the cofactor binding site, as opposed to the substrate
binding site. Such inhibitors would likely be broad spectrum
rather than selective inhibitors, which may be desirable for ther-
apeutic development (Wagner and Jung, 2012).
Significance
In conclusion, we have used structure-guided rational
design to develop a fluorescently tagged SAM analog that
can be used in FP-based screening of compound libraries
for binding to SAM-I riboswitches or other relevant SAM-
binding RNAs and proteins. Our synthetic route enables
facile modification of the ligand and installation of other
functional probes such as biotin, terminal alkyne, or a
cross-linking agent for synthetic biology and chemical
biology applications. Furthermore, we demonstrate the
utility of analyzing multiple riboswitch sequences for the
development of a statistically reliable FP-based HTS assay
for identifying competitive binders. In addition to the ligand
tagging approach being generally applicable to target
many riboswitches, the adaptation of HTS methodologies
to interrogate RNA-small molecule interactions will be
critical to efforts to target other therapeutically relevant
RNA structures.
EXPERIMENTAL PROCEDURES
Preparation of DNA Constructs
Sequences for all DNA templates and primers used in this study are provided in
Table S2. DNA templates corresponding to riboswitch sequences from
different organisms were either amplified by PCR from the genomic DNA or
from a single-stranded oligonucleotide ordered from IDT. The resulting PCR
products were cloned into the pCR2.1-TOPO vector (Invitrogen) following
manufacturer instructions and sequence confirmed.
In Vitro Transcription of RNAs
DNA templates containing the extended T7 promoter sequence and two addi-
tional G nucleotides for increased transcription efficiency were transcribed
in vitro using T7 RNA polymerase (New England Biolabs) at 37C for 2–3 hr.
RNA was purified in a denaturing (7.5 M urea) 6% polyacrylamide gel and
was extracted from gel pieces using Crush Soak buffer (10 mM Tris-HCl, pH
7.5, 200 mM NaCl, and 1 mM EDTA, pH 8.0). RNAs were precipitated with
ethanol and resuspended in TE buffer (10 mM Tris-HCl, pH 8.0, and 1 mM
EDTA). RNA concentrations were measured by the absorbance at 260 nm
using a microvolume UV-Vis spectrophotometer (Nanodrop ND-8000).
Concentration values were corrected for hypochromicity by measuring the
absorbance at 260 nm after hydrolysis with 50 mM sodium carbonate at
95C for 1–2 hr (S.C. Wilson, D.T. Cohen, and M.C.H., unpublished data).
In-Line Probing Assays
In-line probing analysis was performed following standard procedures (Regul-
ski and Breaker, 2008, see supplemental experimental procedures). The signal
intensity for multiple sites of ligand-induced modulation was normalized to the
observed value at the highest ligand concentration, and fraction cleaved was
taken as the average of the data analyzed for each modulation site. Kd values
were determined by fitting the experimental data to a best-fit curve for a 1:1
RNAligand complex.354 Chemistry & Biology 21, 345–356, March 20, 2014 ª2014 ElsevieCuvette-Based Fluorescence Polarization Binding Assays
Fluorescence polarization readings were carried out using a QuantaMaster
fluorescence spectrofluorometer (excitation 646 nm, emission 662 nm, Photon
Technology International). Samples were prepared in 50 ml of TBM buffer
(90 mM Tris base, 89 mM boric acid, and 10 mM MgCl2, pH 7.0) containing
1 mM of C8-Cy5, and saturation binding experiments were performed with
RNA concentrations ranging from 0 to 40 mM. RNA was added successively
to the sample cuvette, and concentration values were corrected for added
volume. Samples were equilibrated at 30C for 2 min prior to each FP
measurement using tubing connecting the cuvette holder to a water bath.
For competitive ligand displacement assays, sampleswere prepared in 50 ml
of TBM buffer containing 1 mM of C8-Cy5 and 10 mM of either Bs SAM-I or Sa
SAM-I RNA, corresponding to 65% fraction bound. Competitor compounds
were added successively to the sample cuvette, and concentration values
were corrected for added volume. Competitor binding experiments to Bs
SAM-I were performed with compound concentrations ranging from 0 to
92 mM for 4 and 0 to 272 mM for 5. For Sa SAM-I, the compound concentration
ranges were 0–94 mM for 4 and 0–362 mM for 5. See also Supplemental
Experimental Procedures.
384-Well Fluorescence Polarization Competition Assays
For 384-well FP competitive ligand displacement assays, samples were pre-
pared from a master mix of TBM buffer containing 1 mM of C8-Cy5 and
10 mM of either Bs, Pi, or Sa SAM-I RNA, with no competitor or with 100 mM
of SAM, SAH sulfone, or adenosine. A multichannel repeat pipettor was
used to manually add 50 ml of samples into 16 replicate wells on a 384-well
plate (Corning low volume flat bottom polystyrene nonbinding surface). FP
measurements were taken on a Molecular Devices FlexStation 3 Plate Reader
at the UCSF Small Molecule Discovery Center.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2014.01.004.
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